drug

Uncategorized

CERo Therapeutics Expands Patent Portfolio with Two Key Approvals for Cancer-Fighting T Cell Therapy

/

In a significant step forward for next-generation immunotherapy, CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) has announced the allowance of two patent applications by the U.S. Patent and Trademark Office (USPTO). These approvals further strengthen the company’s intellectual property portfolio and advance its mission to revolutionize cancer treatment through engineered T cell technology. 🧬 What the […]

Uncategorized

Navigating the Complexities of Biotech Patent Law: A Look at REGENXBIO v. Sarepta Therapeutics

/

The rapidly evolving field of biotech patent law continues to present significant challenges, particularly when it comes to innovations involving recombinant nucleic acids and biological sequences. A recent ruling in REGENXBIO v. Sarepta Therapeutics by the US District Court for the District of Delaware has brought to light critical issues regarding patent eligibility for biotechnological

Uncategorized

GSK Resolves Patent Lawsuit Against Pfizer Over RSV Vaccines

/

Pharmaceutical giants GSK and Pfizer have reached a settlement to resolve a long-running patent dispute related to respiratory syncytial virus (RSV) vaccines. The legal battle, which revolved around patent infringement claims, has now been brought to a close through an agreement between the two companies. The lawsuit centered on allegations that Pfizer’s RSV vaccine infringed

Uncategorized

Hoth Therapeutics Announces Key Developments in HT-KIT Cancer Fighting Drug Candidate

/

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on pioneering therapies for allergic and inflammatory diseases, today revealed two significant advancements in the development of its proprietary antisense oligonucleotide (ASO) cancer-fighting drug candidate, HT-KIT. The company has filed amended claims with the U.S. Patent and Trademark Office to further strengthen the intellectual property protection

Uncategorized

Autonomix Medical, Inc. Awarded U.S. Patent for Advanced Sensing Data Collection and Processing with Proprietary Catheter-Based Technology

/

Autonomix Medical, Inc., a leader in cutting-edge medical technology, is proud to announce the granting of a new U.S. patent that reinforces the company’s position at the forefront of the healthcare industry. The patent covers the innovative sensing data collection and processing capabilities of the company’s proprietary catheter-based technology, a breakthrough that is set to

battle, dispute, drug, linezolid, medicine, patent, pharma, Uncategorized

“Linezolid” Patent Revoked After Post-Grant Opposition by Symed Labs

/

The Indian Patent Office has revoked Patent No. 281489 (Application No. 201641013830) following a post-grant opposition filed by Symed Labs. The patent was granted on 20 March, 2017 and the post grant opposition was filed on 5 March, 2018. The patentee had also amended its claims during the opposition proceedings and urged that the application

anti-ageing, drug, medicine, patent, pharma, technology, Uncategorized

Pharma consultant Agrawal filed patent for new anti-ageing drug

/

Sanjay Agrawal, a scientific advisor for the US-based Alkomex GBN Pharma Group and an Ahmedabad-based researcher, has filed for a patent for an anti-aging drug formulation aimed at combating aging at the cellular level. The formulation is designed to address the underlying biological processes of aging, potentially offering a groundbreaking approach to age-related issues. The

medicine, patent, pharma, technology, Uncategorized

Innocan Pharma secure first patent in India for Liposome Injection

/

Innocan Pharma Corporation has granted its first patent in India for its Liposomal CBD Injection platform. This patent protects the company’s synthetic Cannabidiol-loaded Liposome Injection Platform (LPT-CBD), designed for precise dosing and sustained release of synthetic CBD into the bloodstream. The LPT-CBD platform has received positive feedback from the U.S. Food and Drug Administration (FDA)

Scroll to Top